● Recruiting

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

Condition: Pregnancy Related · Atopic Dermatitis · Sponsor: Incyte Corporation

PhaseN/A

Planned participants5621

Who can joinFemale, 14 Years to no upper limit

Healthy volunteersNo

About this study

This study is to assess infant outcomes of women with AD who were exposed to ruxolitinib cream during pregnancy compared with a control cohort of women with AD who were exposed to a topical corticosteroid (TCS) during pregnancy.

This description comes directly from the study's public registry record.

Talk to the study team

Incyte Corporation Call Center (US) · 1.855.463.3463 · medinfo@incyte.com

Always discuss trial participation with your own doctor first.

Locations (1)

Syneos Health (remote site)

Morrisville, North Carolina, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06627335